Results 171 to 180 of about 12,666,103 (318)

Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene

, 2021
Liang Wang, Huan Li, Yaqin Li, Min Xu, Jinfu Lin, Ziyu Liao, Zhong Pei, Cheng Zhang   +7 more
openalex   +1 more source

The cell cycle in stem cell proliferation, pluripotency and differentiation

Nature Cell Biology, 2019
Lijun Liu, W. Michowski, Aleksandra A. Kolodziejczyk, P. Sicinski   +3 more
semanticscholar   +1 more source

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich, Tilman Schneider‐Hohendorf, Eric Baetscher, Evan L. Riddle, Marie Deffner, Emily Katsnelson, Janine Ferrant‐Orgettas, Julie Czerkowicz, John Anderson, Susan E. Goelz, Nicholas Schwab   +10 more
wiley   +1 more source

Advances in Stem Cell Therapy for Diabetic Foot Ulcers. [PDF]

Diabetes Metab Syndr Obes
Wang B, Zhao G, Zhang J, Chen W, Yang S, Sun Y.   +5 more
europepmc   +1 more source

The TBC1D15 Oncoprotein Controls Stem Cell Self-Renewal through Destabilization of the Numb-p53 Complex

, 2013
Douglas E. Feldman, Chia‐Lin Chen, Vasu Punj, Keigo Machida   +3 more
openalex   +2 more sources

SNUPN‐Related Muscular Dystrophy: Novel Phenotypic, Pathological and Functional Protein Insights

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SNUPN‐related muscular dystrophy or LGMDR29 is a new entity that covers from a congenital or childhood onset pure muscular dystrophy to more complex phenotypes combining neurodevelopmental features, cataracts, or spinocerebellar ataxia. So far, 12 different variants have been described.
Nuria Muelas, Pablo Iruzubieta, Alberto Damborenea, Laura Pérez‐Fernández, Inmaculada Azorín, Juan Carlos Jiménez García, Ana Töpf, Pilar Martí, Lorena Fores‐Toribio, María Manterola, Rosana Blanco‐Mañez, Oihane Pikatza‐Menoio, Sonia Alonso‐Martín, Volker Straub, Aitziber L. Cortajarena, Adolfo López de Munain, David De Sancho, Lorea Blázquez, Juan J. Vilchez   +18 more
wiley   +1 more source

Stem cell mining: urine cells to biobanking. [PDF]

Clin Exp Pediatr
Ahn YJ.
europepmc   +1 more source

Variation in cancer risk among tissues can be explained by the number of stem cell divisions

Science, 2015
C. Tomasetti, B. Vogelstein
semanticscholar   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

Stem cell transplantation cost in Iran. [PDF]

BMC Health Serv Res
Karimi F, Mosadeghrad AM, Vaezi M, Janbabaei G, Ghobeishipour H, Nozarian MH, Mousavi SA, Fumani HK, Rad S, Barkhordar M, Shiraji ST, Ghavamzadeh A, Yaghmaie M.   +12 more
europepmc   +1 more source